Related Experiment Videos
[Chemoembolization of malignant liver tumors]
1Unité de Radiologie Interventionnelle, Institut Gustave Roussy, Villejuif, France.
Acta Gastro-Enterologica Belgica
|September 1, 1990
Summary
Hepatic chemoembolization shows promise for endocrine tumor metastases and hepatocellular carcinoma, inducing partial or complete responses. However, patient selection remains challenging, requiring further evaluation of this interventional radiology technique.
Area of Science:
- Interventional Radiology
- Oncology
- Hepatology
Background:
- Hepatic tumors, including metastases and hepatocellular carcinoma, present significant treatment challenges.
- Hepatic chemoembolization is an interventional radiology technique used for liver tumor treatment.
Purpose of the Study:
- To describe the principles, drugs, vectors, techniques, and contraindications of hepatic chemoembolization.
- To review the efficacy of hepatic chemoembolization for malignant hepatic tumors, particularly hepatocellular carcinoma and endocrine tumor metastases.
Main Methods:
- Literature review of hepatic chemoembolization principles and techniques.
- Analysis of personal experience and published data, including controlled studies, on chemoembolization outcomes.
- Focus on results for endocrine tumor metastases and hepatocellular carcinoma.
Main Results:
- Encouraging results reported for metastases from endocrine tumors and hepatocellular carcinoma.
- Japanese authors and personal series show favorable outcomes in hepatocellular carcinoma.
- Chemoembolization can achieve partial or complete responses in malignant hepatic tumors.
Conclusions:
- Hepatic chemoembolization demonstrates potential for treating specific liver tumors.
- Patient selection criteria for optimal outcomes, especially in hepatocellular carcinoma with underlying liver disease, require further definition.
- Hepatic chemoembolization is considered an evolving technique for malignant hepatic tumors requiring continued evaluation.